Evidence map›Paper›PMID 27175212›Full record

ArticleChinese medicine2016

Antidiabetic and antioxidant effects of catalpol extracted from Rehmannia glutinosa (Di Huang) on rat diabetes induced by streptozotocin and high-fat, high-sugar feed.

Huifeng Zhu, Yuan Wang, Zhiqiang Liu, Jinghuan Wang, Dong Wan, Shan Feng, Xian Yang, Tao Wang

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Huifeng ZhuCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715 China ; Chongqing Engineering Research Center for Pharmacological Evaluation, POB 400715, Chongqing, China.
Yuan WangCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715 China ; Chongqing Engineering Research Center for Pharmacological Evaluation, POB 400715, Chongqing, China.
Zhiqiang LiuDepartment of Pharmacy, The First People's Hospital of Neijiang, Neijiang, 641000 China.
Jinghuan WangCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715 China ; Chongqing Engineering Research Center for Pharmacological Evaluation, POB 400715, Chongqing, China.
Dong WanDepartment of Emergency, The First Affiliated Hospital of Chongqing Medical University, POB 400016, Chongqing, China.
Shan FengCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715 China ; Chongqing Engineering Research Center for Pharmacological Evaluation, POB 400715, Chongqing, China.
Xian YangCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715 China ; Chongqing Engineering Research Center for Pharmacological Evaluation, POB 400715, Chongqing, China.
Tao WangCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing, 400715 China ; Chongqing Engineering Research Center for Pharmacological Evaluation, POB 400715, Chongqing, China.
Southwest University · CNFirst Affiliated Hospital of Chongqing Medical University · CNNeijiang Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes, associated with hyperlipidemia and oxidative stress, would lead to an increased production of reactive oxygen species. Rehmannia glutinosa (Di Huang) is widely used to nourish yin, invigorate the kidney (shen), and treat xiao ke (a diabetes-like syndrome in Chinese medicine). This study aims to investigate the antidiabetic and antioxidant effects of catalpol from R. glutinosa on rat diabetes induced by streptozotocin (STZ) and high-fat, high-sugar feed.

methodsRats (eight rats in each group at least) were induced diabetes by an initial high-fat high-sugar feed for 3 weeks, followed by an intraperitoneal injection of STZ (30 mg/kg) for 3 days, and rats were fasted overnight before treatments. Catalpol at a dose of 0, 5, 10, 20 or 50 mg/kg was administrated through bolus intravenous injection to the experimental rats to find the most effective anti-hyperglycemic dose of catalpol to further study body weight loss, water intake, and food intake. The most effective catalpol dose was given to the diabetic model rats with hyperlipidemia, and the levels of blood sugar, plasma total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were measured after catalpol administration once a day for 2 weeks. An oral glucose challenge test (OGCT) was performed after above experiments in which the most effective dose of catalpol has been determined. Levels of glutathione peroxidase (GSH-PX), catalase (CAT), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured by corresponding reagent kits and morphological changes of the pancreas were observed with histopathological examination using H&E stain.

resultsCatalpol at a dose of 50 mg/kg ameliorated body weight loss and increased water and food intake. Catalpol also attenuated the increase of plasma TC (P = 0.0067) and TG (P = 0.0084) and increased HDL-C (P = 0.0336). The OGCT revealed that catalpol reduced the increase of plasma glucose. The activities of antioxidative enzymes (SOD, P = 0.0037; GSH-PX, P = 0.0066; CAT, P = 0.005) were enhanced and MDA was reduced (P = 0.003). Furthermore, catalpol reduced the morphological impairment of the pancreas.

conclusionCatalpol protected against STZ-induced diabetes with high-fat and high-sugar feed with ameliorated structural impairment of the pancreas and restored balance between oxidative enzymes and antioxidative enzymes.

Identifiers

PMID27175212
PMCPMC4864906
OpenAlexW2390070569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.